Quick Takeaways
- BlackRock Portfolio Management LLC filed SCHEDULE 13G for ANIKA THERAPEUTICS INC Common Stock (ANIK).
- Disclosed ownership: 5.5%.
- Date of event: 30 Sep 2025.
BlackRock Portfolio Management LLC - 30 Sep 2025 SCHEDULE 13G Report for ANIKA THERAPEUTICS INC Common Stock (ANIK)
- Filing Manager
- BlackRock Portfolio Management LLC
- Reporting Manager
- BlackRock Portfolio Management LLC
- Security
- ANIKA THERAPEUTICS INC Common Stock
- Symbol
- ANIK
- Shares outstanding
- 14,424,709 shares
- Disclosed Ownership
- 793,359 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Oct 2025, 12:45:42 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock Portfolio Management LLC disclosed 5.5% ownership in ANIKA THERAPEUTICS INC Common Stock (ANIK) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Oct 2025, 12:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 5.5% | 793,359 | 769,931 | 0 | Spencer Fleming | Managing Director |